Harvard Bioscience, Inc. - HBIO

SEC FilingsOur HBIO Tweets

About Gravity Analytica

Recent News

  • 06.06.2025 - Use of BTX ECM 830 Electroporation System supports research on ependymal cell maturation and Elp3 function
  • 06.05.2025 - John Duke
  • 06.05.2025 - John Duke
  • 06.03.2025 - Advancing Preclinical Alzheimer’s Research with Simultaneous Behavioral and Physiological Data Collection
  • 06.02.2025 - Harvard Bioscience Appoints John Duke to Board of Directors
  • 06.02.2025 - Harvard Bioscience Appoints John Duke to Board of Directors
  • 06.02.2025 - Harvard Bioscience Appoints John Duke to Board of Directors
  • 05.23.2025 - True-to-life ephys recordings from inside an organoid for the first time.
  • 05.23.2025 - Get organoid research updates each month.
  • 05.23.2025 - Unraveling Japanese encephalitis virus attenuation: Insights into vaccine development and viral pathogenicity

Recent Filings

  • 06.02.2025 - 8-K Current report
  • 06.02.2025 - EX-99.1 EX-99.1
  • 05.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.27.2025 - SD Specialized disclosure report
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.14.2025 - 3 Initial statement of beneficial ownership of securities
  • 05.14.2025 - 4 Statement of changes in beneficial ownership of securities